RETHINKING PRESCRIPTIONS: DESIGNING A CLINICAL PROCESS MAP TO MITIGATE DAPAGLIFLOZIN-INDUCED PRESCRIBING CASCADES

Authors

  • RAVINANDAN AP Department of Pharmacy Practice, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bengaluru, Karnataka, India. https://orcid.org/0000-0003-0952-8824
  • ESWARAN MAHESWARI Department of Pharmacy Practice, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bengaluru, Karnataka, India
  • HUNSUR NAGENDRA VISHWAS Department of Pharmacy Practice, JSS College of Pharmacy, Ooty, JSS Academy of Higher Education and Research, The Nilgiris, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2025v18i5.54320

Keywords:

Dapagliflozin, Bacterial infection, Adverse drug reactions, Ciprofloxacin, Tinidazole, Prescribing cascade, Drug-related problem, Clinical process maps

Abstract

A 68-year-old man developed fever, breathlessness, and excessive sweating. He is a known case of type 2 diabetes mellitus; recently, dapagliflozin was prescribed. Dapagliflozin reduces blood glucose by inhibiting selective sodium-glucose cotransporter-2. Sometimes, it induces infection due to an excessive amount of glucosuria. The patient’s laboratory report indicates the bacterial infection and prescribes antibiotics. Occasionally, adverse drug reactions (ADRs) are misinterpreted by doctors as new medical conditions or symptoms, adding one more drug to the treatment chart or prescription needlessly, and this process is called the prescribing cascade (PC). This typical case is also the best example for two different types of PCs, such as an intentional, inappropriate, and prophylactic PC, with pantoprazole and ciprofloxacin and tinidazole as an unintentional and appropriate PC. Because of the PC, patients unnecessarily spend money, increasing the treatment cost. A detailed medical and medication history during the consultation and clinical process maps (CPM) will help minimize this advanced stage of ADRs. CPM are one tool generated using different geometric shapes with various colors. Hence, we have designed the CPM, which can play a pivotal role in diminishing the incidence of ADR and PCs by better understanding

Downloads

Download data is not yet available.

References

Parthasarathi G, Nyfort-Hansen K, Nahata MC. A Textbook of Clinical Pharmacy Practice. 2nd ed. Hyderabad: Universities Press (India) Private Limited.; 2012. p. 104-18.

Walker R, Whittlesea C. Clinical Pharmacy and Therapeutics. 5th ed. Edinburgh: Churchill Livingstone; 2012. p. 62-75.

Naidu SV, Rani V. Profile of adverse drug reactions in a tertiary care Hospital: A cross-sectional study. Asian J Pharm Clin Res. 2024;17(6):178-82.

Rajakannan T, Mallayasamy S, Guddattu V, Kamath A, Vilakkthala R, Rao PG, et al. Cost of adverse drug reactions in a south Indian tertiary care teaching Hospital. J Clin Pharmacol. 2012 Apr;52(4):559-65. doi: 10.1177/0091270011398867 [ePub] 2011 Apr 19, PMID 21505086

Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital--their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003 Dec;12(8):687-92. doi: 10.1002/pds.871, PMID 14762985

Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: The prescribing cascade. BMJ. 1997;315(7115):1096-9. doi: 10.1136/ bmj.315.7115.1096, PMID 9366745

Rochon PA, Gurwitz JH. Drug therapy. Lancet. 1995;346(8966):32-6. doi: 10.1016/s0140-6736(95)92656-9, PMID 7603146

Kalisch LM, Caughey GE, Roughead EE, Gilbert AL. The prescribing cascade. Aust Prescr. 2011;34(6):162-6. doi: 10.18773/ austprescr.2011.084

Rochon PA, Gurwitz JH. The prescribing cascade revisited. Lancet. 2017;389(10081):1778-80. doi: 10.1016/S0140-6736(17)31188-1, PMID 28495154

Chen Z, Liu Z, Zeng L, Huang L, Zhang L. Research on prescribing cascades: A scoping review. Front Pharmacol. 2023 Jul 3;14:1147921. doi: 10.3389/fphar.2023.1147921, PMID 37465527, PMCID PMC10350531

Sauriasari R, Sakti RM. Impact of a pharmacist-led patient education initiative on glycemic control of patients with type 2 diabetes mellitus: A single-center experience in West Jakarta, Indonesia. Int J App Pharm. 2018;10(1):252-6. doi: 10.22159/ijap.2018.v10s1.56

Drugs.com. Drugs.com is the most popular, comprehensive, and up-to-date source of drug information online [Internet]. Available from: https://www.drugs.com/dapagliflozin.html [Last accessed on 25 Jan 2024].

Shakir Basha S, Sravanthi P. Development and validation of dapagliflozin by reversed-phase high-performance liquid chromatography method and its forced degradation studies. Asian J Pharm Clin Res. 2017;10(11):101-5. doi: 10.22159/ajpcr.2017.v10i11.19705

Bisht R. Sodium-glucose linked cotransporter 2 inhibitor: A new horizon in the treatment of type-2 diabetes. Asian J Pharm Clin Res. 2021;14(3):45-8. doi: 10.22159/ajpcr.2021.v14i3.39667

Arakaki RF. Sodium-glucose cotransporter-2 inhibitors and genital and urinary tract infections in type 2 diabetes. Postgrad Med. 2016;128(4):409-17. doi: 10.1080/00325481.2016.1167570, PMID 26982554

Medscape from Web MD. Medscape from Web MD is a Part of Web MD Health Professional Network. Available from: https://reference. medscape.com/drug/farxiga-dapagliflozin-999899#4 [Last accessed on 2024 Jan 25].

Verma MV, Patel CJ, Patel MM. Development and stability indicating HPLC method for dapagliflozin in API and pharmaceutical dosage form. Int J Appl Pharm. 2017;9(5):33-41. doi: 10.22159/ijap.2017v9i5.19185

Ponte ML, Wachs L, Wachs A, Serra HA. Prescribing cascade. A proposed new way to evaluate it. Medicina (B Aires). 2017;77(1):13-6. PMID 28140305

Becerra AF, Boch M, Al-Mezrakchi YA. Ropinirole-associated orthostatic hypotension as cause of a prescribing cascade in an elderly Man. Cureus. 2021 Jun 7;13(6):e15506. doi: 10.7759/cureus.15506, PMID 34268037, PMCID PMC8261795

Ahmad R, Narwaria M, Singh A, Kumar S, Haque M. Detecting diabetic ketoacidosis with infection: Combating a life-threatening emergency with practical diagnostic tools. Diagnostics (Basel). 2023 Jul 21;13(14):2441. doi: 10.3390/diagnostics13142441, PMID 37510185, PMCID PMC10378387

Centers for Disease Control and Prevention. How Diabetes Affects your Immune System. Atlanta: CDC; 2023. Available from: https://www. cdc.gov/diabetes/diabetes-complications/diabetes-immune-system. html [Last accessed on 2025 Apr 01].

Lavanya G, Makarandh A, Venkateshwarlu E, Sharavanabhava BS, Sathyanarayana K. A comparative study to assess the safety and efficacy of some oral triple therapy regimens in patients with uncontrolled type 2 diabetes mellitus. Int J Pharm Pharm Sci. 2025;17(1):28-35.

Filippatos TD, Liberopoulos EN, Elisaf MS. Dapagliflozin in patients with type 2 diabetes mellitus. Ther Adv Endocrinol Metab. 2015;6(1):29-41. doi: 10.1177/2042018814558243, PMID 25678954

Dreischulte T, Shahid F, Muth C, Schmiedl S, Haefeli WE. Prescribing cascades: How to detect them, prevent them, and use them appropriately. Dtsch Ärztebl Int. 2022 Nov 4;119(44):745-52. doi: 10.3238/arztebl. m2022.0306, PMID 36045504, PMCID PMC9853235

NHS Website. UK: National Health Service; 2022. Side Effects of Dapagliflozin. Available from: https://www.nhs.uk/medicines/ dapagliflozin/side-effects-of-dapagliflozin/?utm-source [Last accessed on 2025 Feb 15].

Mayo Clinic. Fever: First Aid. Mayo Clinic Publications; 2022. Available from: https://www.mayoclinic.org/first-aid/first-aid-fever/ basics/art-20056685 [Last accessed on 2025 Feb 15].

Narwat A, Goyal A, Bhati R. A systematic review on adherence to oral antidiabetic drugs in patients with type 2 diabetes mellitus. Int J Curr Pharm Res. 2024;16(6):11-3. doi: 10.22159/ijcpr.2024v16i6.5091

NHS Institute for Innovation and Improvement. Process Mapping, Analysis, and Redesign: General Improvement Skills. United Kingdom: NHS Institute for Innovation and Improvement; 2005.

Piggott KL, Mehta N, Wong CL, Rochon PA. Using a clinical process map to identify prescribing cascades in your patient. BMJ. 2020 Feb 19;368:m261. doi: 10.1136/bmj.m261, PMID 32075785

Published

07-05-2025

How to Cite

RAVINANDAN AP, et al. “RETHINKING PRESCRIPTIONS: DESIGNING A CLINICAL PROCESS MAP TO MITIGATE DAPAGLIFLOZIN-INDUCED PRESCRIBING CASCADES”. Asian Journal of Pharmaceutical and Clinical Research, vol. 18, no. 5, May 2025, pp. 1-4, doi:10.22159/ajpcr.2025v18i5.54320.

Issue

Section

Case Study(s)